People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Resolvyx Pharmaceuticals, Inc. | — | Biotechnology | Seed | $3.7M | $111.0M | 2010 |
JEAN-FRANCOIS J. FORMELA at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside JEAN-FRANCOIS J. FORMELA on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Timothy J. Barberich | 1 | 7 |
| Douglas J. Cole | 1 | 2 |
| George M. Milne, Jr. | 1 | 2 |
| PER GJORSTRUP | 1 | 1 |
| KEITH J. MANCHESTER | 1 | 1 |
| C. ERIC SCHWARTZ | 1 | 1 |
| JAMES NICHOLS | 1 | 1 |
| GREGORY M. WEINHOFF | 1 | 1 |
| JAMES J. NICHOLS | 1 | 1 |
| PHILIP J. VICKERS | 1 | 1 |
| PER J. GJORSTRUP | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.